1. Home
  2. PRAX vs SSB Comparison

PRAX vs SSB Comparison

Compare PRAX & SSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$327.28

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo SouthState Corporation

SSB

SouthState Corporation

HOLD

Current Price

$101.35

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SSB
Founded
2015
1933
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
9.7B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
PRAX
SSB
Price
$327.28
$101.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
13
Target Price
$572.13
$118.00
AVG Volume (30 Days)
560.5K
664.6K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
2.49%
EPS Growth
N/A
12.91
EPS
N/A
2.28
Revenue
N/A
N/A
Revenue This Year
N/A
$10.07
Revenue Next Year
$7,758.26
$6.51
P/E Ratio
N/A
$44.21
Revenue Growth
N/A
N/A
52 Week Low
$37.25
$84.48
52 Week High
$366.52
$108.46

Technical Indicators

Market Signals
Indicator
PRAX
SSB
Relative Strength Index (RSI) 57.49 62.95
Support Level $308.40 $92.40
Resistance Level $327.65 $102.18
Average True Range (ATR) 17.85 1.92
MACD 8.65 0.48
Stochastic Oscillator 83.99 81.63

Price Performance

Historical Comparison
PRAX
SSB

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SSB SouthState Corporation

SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.

Share on Social Networks: